CLARITHROMYCINE EVOLUGEN 500 mg, modified-release film-coated tablet 10 tablets
Active ingredients: Clarithromycin
Commercialized according to BDPMDispensing in France: Prescription only
Modified-release film-coated tablet10 tabletsorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- CLARITHROMYCINE EVOLUGEN 500 mg, comprimé pelliculé à libération modifiée
- Pharmaceutical form
- comprimé pelliculé à libération modifiée
- Route of administration
- orale
- Presentation description
- plaquette(s) PVC (ACLAR RX) polytrifluorochloroéthylène aluminium de 10 comprimé(s)
- Marketing authorisation holder
- EVOLUPHARM
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 26 Jan 2022
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
66142160CIP74948629CIP133400949486298Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| CLARITHROMYCINEcomprimé | 500 mg · un comprimé | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.